Skip to content
BuySemaglutide.ca
Mounjaro

Mounjaro in Canada

Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist approved by Health Canada for type 2 diabetes and prescribed off-label for weight management. Its dual mechanism differs from semaglutide. Pricing varies by dose — explore the guides below, or compare providers to see current program pricing.

Guides & Articles

Mounjaro by Province

Provincial drug plan coverage, Special Authority requirements, and provider availability vary. Select your province for details.

Mounjaro by City

Coverage and availability follow your province's rules — find your city below.

Find out if Mounjaro or a lower-cost alternative is right for you

Complete a short eligibility assessment and compare licensed Canadian providers.